BeOne Medicines (ONC) Shares Issued (2016 - 2026)

BeOne Medicines (ONC) has 11 years of Shares Issued data on file, last reported at $23.9 million in Q1 2026.

• Quarterly Shares Issued fell 62.32% year-over-year to $23.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $156.8 million (up 66.91% YoY) and the FY2025 annual result came in at $196.3 million, up 332.59% from the prior year.
• Shares Issued rose to $23.9 million in Q1 2026 per ONC's latest filing, from $19.2 million in the prior quarter.
• Across five years, Shares Issued topped out at $80.5 million in Q3 2025 and bottomed at $3.4 million in Q4 2023.
• The 5-year median for Shares Issued is $16.2 million (2024), against an average of $21.7 million.
• The widest annual swing landed in 2022, when Shares Issued surged 33310.0%; it then tumbled 70.23% in 2023.
• Tracing ONC's Shares Issued over 5 years: stood at $11.3 million in 2022, then plunged by 70.23% to $3.4 million in 2023, then jumped by 161.76% to $8.8 million in 2024, then soared by 118.79% to $19.2 million in 2025, then increased by 24.07% to $23.9 million in 2026.
• Per Business Quant, the three latest ONC Shares Issued figures stand at $23.9 million (Q1 2026), $19.2 million (Q4 2025), and $80.5 million (Q3 2025).

Peer Comparison